2'-o-methyladenosine has been researched along with Hepatitis C in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyer, SH; Erion, MD; Fujitaki, JM; Hecker, SJ; Huang, W; Koeplinger, KA; Linemeyer, DL; MacCoss, M; Olsen, DB; Reddy, KR; Reddy, MV; Sun, Z; van Poelje, PD; Varkhedkar, V | 1 |
1 other study(ies) available for 2'-o-methyladenosine and Hepatitis C
Article | Year |
---|---|
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
Topics: Adenosine; Administration, Oral; Animals; Antiviral Agents; Biological Availability; Hepatitis C; Hepatocytes; Injections, Intravenous; Liver; Organophosphates; Organophosphorus Compounds; Phosphorylation; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2007 |